MAINTENANCE STUDY OF IDURONATE-2-SULFATASE REPLACEMENT THERAPY IN MPS II PATIENT

MPS II 患者艾杜糖酸-2-硫酸酯酶替代治疗的维持研究

• 批准号: 7377421
• 负责人: JOSEPH J. MUENZER
• 金额: $ 0.89万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7377421
• 关键词: MAINTENANCE; STUDY; IDURONATE; SULFATASE; REPLACEMENT

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to continue to test the safety and effectiveness of the experimental enzyme, iduronate-2-sulfatase (I2S) replacement treatment for mucopolysaccharidosis II (MPS II), which is also called Hunter syndrome.

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。这项研究的目的是继续测试实验酶艾杜糖酸-2-硫酸酯酶(I2S)替代治疗粘多糖病II(MPS II)的安全性和有效性，MPS II也称为Hunter综合征。